Qinghai Gelatin to Sell TCM Subsidiary to Chongqing Lummy Pharma
December 09, 2010 at 15:21 PM EST
Qinghai Gelatin has reached a framework agreement to sell its drug making subsidiary, Sichuan Hezheng Pharmaceutical, to Chongqing Lummy Pharmaceutical for 90 million RMB ($13.5 million). Hezheng Pharma produces TCM products in the form of pills, granules, capsules, tablets, and non-food health products. More details.... Stock Symbols: (SHEX: 000606) (SHEX: 300006)